Total Payments
$6,012
2024 Payments
$170.03
Companies
25
Transactions
332
Medicare Patients
1,119
Medicare Billing
$165,989
Payment Breakdown by Category
Food & Beverage$5,112 (85.0%)
Consulting$800.00 (13.3%)
Education$99.99 (1.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,112 | 330 | 85.0% |
| Consulting Fee | $800.00 | 1 | 13.3% |
| Education | $99.99 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,613 | 93 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,052 | 92 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $800.00 | 1 | $0 (2021) |
| Novo Nordisk Inc | $658.01 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $411.51 | 21 | $0 (2024) |
| Astellas Pharma US Inc | $307.68 | 13 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $305.92 | 17 | $0 (2024) |
| Daiichi Sankyo Inc. | $176.74 | 25 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $158.06 | 10 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $98.13 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $170.03 | 8 | Bayer Healthcare Pharmaceuticals Inc. ($94.04) |
| 2023 | $596.67 | 35 | Novo Nordisk Inc ($195.50) |
| 2022 | $944.54 | 51 | Novo Nordisk Inc ($320.42) |
| 2021 | $1,584 | 51 | Paratek Pharmaceuticals, Inc. ($800.00) |
| 2020 | $620.12 | 49 | GlaxoSmithKline, LLC. ($202.96) |
| 2019 | $666.40 | 40 | AstraZeneca Pharmaceuticals LP ($300.18) |
| 2018 | $697.40 | 38 | AstraZeneca Pharmaceuticals LP ($233.96) |
| 2017 | $732.99 | 60 | AstraZeneca Pharmaceuticals LP ($225.20) |
All Payment Transactions
332 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Cardio-renal | ||||||
| 03/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Cardio-renal | ||||||
| 02/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Respiratory | ||||||
| 02/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Cardio-renal | ||||||
| 02/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.07 | General |
| 01/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $34.93 | General |
| Category: Cardio-renal | ||||||
| 01/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: RESPIRATORY | ||||||
| 01/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Diabetes | ||||||
| 11/30/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Respiratory | ||||||
| 11/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Respiratory | ||||||
| 09/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/07/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Diabetes | ||||||
| 08/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: RESPIRATORY | ||||||
| 07/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Respiratory | ||||||
| 07/13/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Cardio-renal | ||||||
| 06/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Diabetes | ||||||
| 06/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Cardio-renal | ||||||
| 06/15/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Respiratory | ||||||
| 06/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.26 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Diabetes | ||||||
| 05/25/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 209 | 422 | $54,194 | $27,457 |
| 2022 | 6 | 233 | 619 | $63,290 | $32,508 |
| 2021 | 4 | 253 | 833 | $72,285 | $44,335 |
| 2020 | 5 | 424 | 1,248 | $108,708 | $61,688 |
Total Patients
1,119
Total Services
3,122
Medicare Billing
$165,989
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 242 | $36,254 | $19,068 | 52.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 90 | $9,054 | $5,055 | 55.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $3,600 | $1,684 | 46.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 18 | 36 | $3,744 | $1,293 | 34.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 13 | 15 | $1,200 | $292.43 | 24.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 19 | $342.00 | $64.79 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 289 | $38,148 | $20,795 | 54.5% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 65 | 224 | $16,800 | $8,755 | 52.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 27 | 39 | $4,056 | $1,217 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 21 | $1,908 | $1,169 | 61.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 21 | 25 | $2,000 | $499.75 | 25.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 21 | $378.00 | $72.48 | 19.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 132 | 416 | $43,264 | $27,226 | 62.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 75 | 347 | $26,025 | $16,384 | 63.0% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 25 | 28 | $2,240 | $579.48 | 25.9% |
| 81002 | Urinalysis, manual test | Office | 2021 | 21 | 42 | $756.00 | $146.16 | 19.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 192 | 606 | $63,024 | $36,244 | 57.5% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 129 | 504 | $37,800 | $23,677 | 62.6% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 45 | 53 | $4,240 | $1,155 | 27.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 32 | 40 | $2,834 | $456.59 | 16.1% |
| 81002 | Urinalysis, manual test | Office | 2020 | 26 | 45 | $810.00 | $155.41 | 19.2% |
About Dr. Adolfo Dulay, MD
Dr. Adolfo Dulay, MD is a Family Medicine healthcare provider based in Madison, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1033110713.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adolfo Dulay, MD has received a total of $6,012 in payments from pharmaceutical and medical device companies, with $170.03 received in 2024. These payments were reported across 332 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,112).
As a Medicare-enrolled provider, Dulay has provided services to 1,119 Medicare beneficiaries, totaling 3,122 services with total Medicare billing of $165,989. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Madison, FL
- Active Since 08/03/2005
- Last Updated 02/22/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033110713
Products in Payments
- NUZYRA (Drug) $800.00
- TRELEGY ELLIPTA (Drug) $621.50
- BREZTRI (Drug) $350.48
- FARXIGA (Drug) $341.56
- Rybelsus (Drug) $322.30
- BEVESPI AEROSPHERE (Drug) $310.53
- Kerendia (Drug) $305.92
- SYMBICORT (Drug) $228.67
- Ozempic (Drug) $214.19
- MYRBETRIQ (Drug) $207.69
- ANORO (Drug) $197.78
- Movantik (Drug) $176.74
- STIOLTO RESPIMAT (Drug) $159.33
- JARDIANCE (Drug) $140.65
- ANORO ELLIPTA (Drug) $113.30
- JANUVIA (Drug) $93.32
- BRILINTA (Drug) $91.49
- BREO (Drug) $76.43
- ENTRESTO (Drug) $75.89
- BELSOMRA (Drug) $49.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Madison
Gary Johnson, Md, MD
Family Medicine — Payments: $301,766
Family Medicine $301,766
Dr. Frederick Freitag, D.o, D.O
Family Medicine — Payments: $228,855
Family Medicine $228,855
Michael Ostrov, Md, MD
Family Medicine — Payments: $160,148
Family Medicine $160,148
Lewis Johnston, M.d, M.D
Family Medicine — Payments: $26,320
Family Medicine $26,320
James Bigham, Md, MD
Family Medicine — Payments: $26,208
Family Medicine $26,208
Dr. Peter Geleskie, M.d, M.D
Family Medicine — Payments: $22,887
Family Medicine $22,887